Infusystem Holdings, INC Form 4 insider transactions

Executive VP and CFO Barry G. Steele acquired over 37,000 shares through the vesting of restricted stock units, signaling continued alignment with shareholder interests.

EVP-Chief HR Officer Jerod Funke acquired 19,753 shares through RSU vestings, bringing his total direct ownership to 29,654 shares.

President and CEO Carrie Lachance acquired over 41,000 shares through the vesting of restricted stock units, bringing her total direct holdings to 266,391 shares.

Executive VP and CIO Addam Chupa acquired over 22,000 shares through the vesting of restricted stock units, bringing his total direct ownership to 61,160 shares.

Director Ronald T. Hundzinski was granted 24,890 stock options in InfuSystem Holdings, Inc. as part of an equity incentive.

Director Scott Shuda was granted 24,890 stock options in InfuSystem Holdings, Inc. as part of a standard equity compensation arrangement.

InfuSystem Holdings, Inc. director John J. Sviokla was granted 24,890 stock options as part of standard equity compensation.

InfuSystem Holdings, Inc. Executive VP and CIO Addam Chupa was granted stock options and restricted stock units as part of an equity compensation package.

InfuSystem Holdings, Inc. director Beverly A. Huss was granted 24,890 stock options as part of a standard equity compensation plan.

Director Paul Gendron was granted 24,890 stock options in InfuSystem Holdings, Inc. as part of a standard equity compensation arrangement.

InfuSystem Holdings, Inc. Executive VP and CFO Barry G. Steele was granted stock options and restricted stock units on May 12, 2026.

InfuSystem Holdings, Inc. CEO Carrie Lachance was granted stock options and restricted stock units as part of an equity compensation package.

EVP and Chief HR Officer Jerod Funke was granted stock options and restricted stock units by InfuSystem Holdings, Inc.

Director Kenneth D. Eichenbaum was granted 24,890 stock options in InfuSystem Holdings, Inc. as part of an equity incentive.

Director Paul Andrew Gendron acquired 5,000 shares of InfuSystem Holdings, Inc. common stock for $8.88 per share.

Carrie Lachance, President and CEO of InfuSystem Holdings, Inc., has acquired additional shares of common stock through recent transactions.

Barry G. Steele, Executive VP and CFO of InfuSystem Holdings, Inc., acquired 7,000 shares of common stock.

InfuSystem Holdings, Inc.'s Executive VP and CFO, Barry G. Steele, acquired 2,064 shares of common stock at a weighted average price of $9.16.

InfuSystem Holdings' EVP-Chief HR Officer, Jerod Funke, acquired 12,500 shares through RSU vesting and sold 3,669 shares for tax obligations.

InfuSystem Holdings, Inc. President and CEO Carrie Lachance reported the vesting of 50,000 performance-based restricted stock units and the subsequent disposition of 19,675 shares for tax liability.

InfuSystem Holdings Director Scott Shuda reported the sale and distribution of company shares following the dissolution of a partnership.

InfuSystem Holdings, Inc. Director Kenneth D. Eichenbaum has acquired 2,000 shares of common stock at a weighted average price of $5.18, increasing his direct beneficial ownership to 6,000 shares.

Kenneth D. Eichenbaum, a director of InfuSystem Holdings, Inc., was granted stock options to purchase 39,588 shares of common stock.

Jerod Funke, EVP-Chief HR Officer of InfuSystem Holdings, reports the acquisition of restricted stock units and stock options.

Carrie Lachance, President and COO of InfuSystem Holdings, reports acquisition and disposal of common stock and derivative securities.

Paul Gendron, a director at InfuSystem Holdings, reported the acquisition of stock options and the disposal of common stock.

Director Ronald T. Hundzinski reports the acquisition of 5,000 shares of InfuSystem Holdings, Inc. common stock and stock options for 39,588 shares.

Executive VP and CIO Addam Chupa reports acquisition and disposal of InfuSystem Holdings stock and stock options.

Director Scott Shuda reports acquisition of stock options and beneficial ownership of InfuSystem Holdings, Inc. shares.

Richard Dilorio, CEO of InfuSystem Holdings, reports acquisition and disposal of common stock and restricted stock units.